Shunichiro Kawabata

Title: Shunichiro Kawabata: Innovator in Lipopolysaccharide Binding Protein

Introduction

Shunichiro Kawabata is a notable inventor based in Fukuoka, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of proteins that interact with lipopolysaccharides. His work has implications for medical applications, especially in the detection and removal of endotoxins.

Latest Patents

Kawabata holds a patent for a lipopolysaccharide binding protein and the process for producing the same. This invention involves isolating a lipopolysaccharide (LPS) binding protein from horseshoe crabs. The process includes extracting the hemocyte membrane fraction of the horseshoe crab using a polyethylene glycol ether type nonionic surface active agent in the presence of calcium ions. The extract is then combined with immobilized LPS, allowing the binding protein to form a complex. Finally, the LPS binding protein is harvested using a chelating agent. The isolated protein has a molecular weight of approximately 27,000 daltons and is effective in binding lipopolysaccharide endotoxins. This innovation can be utilized for detecting endotoxins and removing them from injectable medicines.

Career Highlights

Kawabata is associated with Seikagaku Kogyo Kabushiki Kaisha, a company known for its advancements in biopharmaceuticals. His work has led to significant advancements in the understanding and application of LPS binding proteins.

Collaborations

Kawabata has collaborated with notable colleagues such as Sadaaki Iwanaga and Tetsu Saito. Their combined expertise has contributed to the successful development of innovative biotechnological solutions.

Conclusion

Shunichiro Kawabata's contributions to the field of biochemistry, particularly through his patent on lipopolysaccharide binding proteins, highlight his role as an influential inventor. His work continues to impact medical science and the development of safer injectable medicines.